Original news and analysis on international IP policy
Por David Cronin para Intellectual Property Watch BRUSELAS – Aumenta la preocupación tanto en Europa como en los países en desarrollo sobre si diversos acuerdos de libre comercio, cuya firma está programada para finales del presente año, contendrán normas demasiado…
By Jia Hepeng for Intellectual Property Watch
BEIJING - China is proposing a fund to help its enterprises cope with rising international litigation related to intellectual property rights (IPRs).
The message, together with other measures, was delivered by Zhang Qin, deputy director of the State Intellectual Property Office (SIPO) at a national corporate IPR meeting on 2 September, but it was not made public until 10 September.
Sun Pingping, a spokeswoman of SIPO, confirmed the news, saying the scale and detailed operation of the fund have not been finalised.
Zhang told the corporate meeting that international legal cases on IP that Chinese enterprises face have been growing. While some of the lawsuits arise from Chinese enterprises' poor IPR awareness and ownership, it is possible that some multinationals are abusing IPR to block the rise of Chinese firms, he said.
By David Cronin for Intellectual Property Watch A dispute has erupted between two of the European Union’s most powerful institutions over Thailand’s decision to circumvent pharmaceutical patents in order to boost its supply of cheap medicines. Peter Mandelson, who holds…
By Tatum Anderson for Intellectual Property Watch As Indian lawyers for Swiss pharmaceutical firm Novartis comb through a High Court judgment published today, the question of whether the Indian patent law is compliant with a World Trade Organization treaty remains…
By Tove Iren S. Gerhardsen Officials from the governments of China and India discussed challenges in developing national strategies for intellectual property and innovation at a recent colloquium, but common to both countries were aims to boost local innovation by…
By Tatum Anderson for Intellectual Property Watch
A debate over how long to give exclusive rights over data submitted by pharmaceutical companies to governments in order to receive approval to sell a drug in their markets is controversial not only in India, but worldwide.
By Tatum Anderson for Intellectual Property Watch
When the Indian government published its report recently on yet another pharmaceutical patent-related issue predicted to split the industry, the Indian newspapers were divided as to whether brand name producers, generics producers or public health advocates had won.
The reason for the confusion is that the report is an exercise in appeasement, said Shamnad Basheer, a law professor at George Washington University Law School, and expert on this latest controversial subject, called data exclusivity, which is the rights drugs producers have over the data used to obtain marketing approval in a country.
By Tatum Anderson for Intellectual Property Watch The latest chapter in the Swiss pharmaceutical company Novartis’ challenge to the Indian intellectual property system begins on 18 June when the Indian Patent and Trademark Appellate Board (IPAB) is scheduled to hold…
Par William New BEIJING – Des pays en développement de premier plan tels que la Chine, le Brésil, l’Inde et l’Afrique du Sud redoublent d’efforts, dans la mesure de leur puissance économique grandissante, pour influencer l’établissement des standards internationaux. De…
By William New BEIJING – China’s rapid development can be seen everywhere in the capital, where the skyline is perforated by construction cranes in all directions. But China’s vigorous effort to update structures does not stop at its borders. China…
By Tove Iren S. Gerhardsen
NEW YORK - A United States official who presented the arguments for why the United States has taken China to the World Trade Organization (WTO) for alleged breaches of trade law related to intellectual property rights and market access was met with strong support from industry and lawyers, but equally strong criticism from others at a recent conference.
By William New BEIJING – Open-source software is receiving a rapid uptake in key developing countries and users, local industries and governments say it offers them market opening, flexibility and lower costs. China, perhaps the biggest potential market, showed last…